This site is intended for healthcare professionals
Micrograph of a prostate carcinoma with atypical mitosis rendered in green
HSPC: Navigating Risk and Management

HSPC quiz

Last updated: 17th Mar 2026
Published: 17th Mar 2026

How much do you know about optimizing care for people with non-metastatic (nm) or metastatic (m) hormone-sensitive prostate cancer (HSPC)? Take this quiz to find out. We’ll ask you the questions again after you’ve watched the HSPC Unlocked podcast series to see what you recall.

1. What is a key challenge in implementing multidisciplinary teams (MDTs) across nations?
2. Which of the following treatments is now recommended by guidelines for patients with high-risk biochemically recurrent (BCR) non-metastatic hormone-sensitive (nmHSPC) prostate cancer who are unsuitable for salvage radiation?
3. Which emerging target is under clinical investigation for metastatic hormone-sensitive prostate cancer (mHSPC)?